The SCFFbw7 Substrate Cycle: phosphodegron processing and nucleolar translocation
SCFFbw7 底物循环:磷酸化降解子加工和核仁转位
基本信息
- 批准号:8912922
- 负责人:
- 金额:$ 39.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:BindingCell LineCell NucleolusCellsClustered Regularly Interspaced Short Palindromic RepeatsComplexConsensusConsensus SequenceCoupledCyclin EEnvironmentEventExclusionExhibitsGoalsHumanIndividualJUN geneKnock-in MouseLigaseMalignant NeoplasmsMediatingMolecularMutateNuclearOrthologous GenePathway interactionsPeptide HydrolasesPeptidylprolyl IsomerasePhosphoserinePhosphothreoninePositioning AttributeProcessProlinePropertyProtein IsoformsProteolysisRegulationResearchSpecificitySubstrate CyclingTechnologyTestingUbiquitinUbiquitin-mediated Proteolysis PathwayVariantYeastsc-myc Genescis trans isomerizationdesigngenetic regulatory proteinhuman CCNE1 proteinmutantprolyl-prolinepublic health relevanceresearch studyubiquitin ligase
项目摘要
DESCRIPTION (provided by applicant): SCFFbw7 is a multisubunit ubiquitin ligase that targets number important cellular regulatory proteins for ubiquitin mediated proteolysis. Targeting of these substrates is mediated via the specificity factor Fbw7, which recognizes a somewhat degenerate consensus sequence known as the CPD (for Cdc4 PhosphoDegron; Cdc4 is the yeast ortholog of Fbw7). Although there is significant variation between individual CPDs, the consensus is invariant in demanding a phosphothreonine (less frequently a phosphoserine) at position 0 and a proline at position +1. However, for most vertebrate substrates of SCFFbw7, there is a second proline at position +2, a sequence motif not observed in yeast substrates of SCFCdc4. Nevertheless, SCFCdc4 is competent to ubiquity late mammalian substrates containing the proline-proline sequence. This observation suggests that the proline-proline motif has evolved to carry out an additional function. We have shown for one substrate, human cyclin E1, that although the second proline is not important for ubiquitylation and proteolysis, per se, it does have a profound effect on certain aspects of cyclin E turnover. Specifically, this second proline is required for translocation of phosphorylated cyclin E into the
nucleolus where ubiquitylation is carried out by SCF constituted with a nucleolus-specific Fbw7 isoform, Fbw7. Nucleolar translocation requires both the nuclear Fbw7 isoform, Fbw7a, and the prolyl peptidyl cis-trans isomerase Pin1, which collaborate to carry out a non-cannonical isomerization of the proline-proline bond rather than the phosphothreonine-proline bond, as is typically the case for Pin1. The general goal of the proposed research is to understand the mechanism whereby a proline-proline bond in conjunction with Fbw7a and Pin1 undergoes cis-trans isomerization and promotes cyclin E nucleolar translocation, and to determine why ubiquitin-mediated proteolysis of cyclin E has evolved to incorporate nucleolar translocation. Finally, we will determine whether other SCFFbw7 substrates that contain a proline-proline sequence at an equivalent position in their phosphodegrons also exhibit Pin1- dependent isomerization and nucleolar translocation coupled to their degradation.
描述(由适用提供):SCFFBW7是一种多亚基泛素连接酶,靶向数量重要的细胞调节蛋白用于泛素介导的蛋白水解。这些底物的靶向是通过特异性因子FBW7介导的,该因子FBW7识别出一种称为CPD的变性共识序列(对于CDC4磷酸根; Cdc4; Cdc4是FBW7的酵母直立性)。尽管单个CPD之间存在显着差异,但在要求在0位0和位置+1处的磷酸硫氨酸(磷serine频率较低)的共识是不变的。但是,对于大多数SCFFBW7的脊椎动物底物,位置+2的第二个脯氨酸,在SCFCDC4的酵母底物中未观察到序列基序。然而,SCFCDC4具有含有脯氨酸丙啉序列的无处不在的晚期哺乳动物底物。该观察结果表明,脯氨酸基序已经进化以执行额外的功能。我们已经显示了一种底物人类细胞周期蛋白E1,尽管第二个脯氨酸对于泛素化和蛋白水解并不重要,但本身确实对Cyclin e离职的某些方面产生了深远的影响。具体而言,第二个脯氨酸是将磷酸化的细胞周期蛋白E转移到该脯氨酸中所必需的
核仁由SCF配置为核特异性FBW7同工型FBW7进行泛素化。核仁易位需要核FBW7同工型,FBW7A和脯氨酰肽基顺式跨性异构酶PIN1,它们合作以对脯氨酸 - 丙啉键而不是磷酸胆红素 - 丙啉键进行非通道异构化,因为PIN1通常是PIN1的情况。拟议研究的一般目标是了解与FBW7A和PIN1结合的脯氨酸键键进行的机制,从而经历顺式传播异构化并促进细胞周期蛋白E核易位,并确定为什么泛素介导的细胞周期蛋白E的蛋白水解促进了细胞周期蛋白E的蛋白水解以融合了核转运。最后,我们将确定其他在其磷draphodgrons中等效位置的脯氨酸序列的SCFFBW7底物是否还表现出依赖性PIN1依赖性异构化和核仁易位与其降解相连。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven I Reed其他文献
Steven I Reed的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven I Reed', 18)}}的其他基金
Fbw7 as a therapeutic target for treating ischemic brain injury
Fbw7作为治疗缺血性脑损伤的治疗靶点
- 批准号:
8987383 - 财政年份:2015
- 资助金额:
$ 39.14万 - 项目类别:
Fbw7 as a therapeutic target for treating ischemic brain injury
Fbw7作为治疗缺血性脑损伤的治疗靶点
- 批准号:
9063625 - 财政年份:2015
- 资助金额:
$ 39.14万 - 项目类别:
Fbw7 as a therapeutic target for treating ischemic brain injury
Fbw7作为治疗缺血性脑损伤的治疗靶点
- 批准号:
9247857 - 财政年份:2015
- 资助金额:
$ 39.14万 - 项目类别:
The role of Cyclin E in growth control and tumorogenesis
Cyclin E 在生长控制和肿瘤发生中的作用
- 批准号:
8787588 - 财政年份:2014
- 资助金额:
$ 39.14万 - 项目类别:
Fbw7 as a therapeutic target for treating Parkinson's disease
Fbw7作为治疗帕金森病的治疗靶点
- 批准号:
9084633 - 财政年份:2014
- 资助金额:
$ 39.14万 - 项目类别:
Fbw7 as a therapeutic target for treating Parkinson's disease
Fbw7作为治疗帕金森病的治疗靶点
- 批准号:
8786965 - 财政年份:2014
- 资助金额:
$ 39.14万 - 项目类别:
Fbw7 as a therapeutic target for treating Parkinson's disease
Fbw7作为治疗帕金森病的治疗靶点
- 批准号:
8850907 - 财政年份:2014
- 资助金额:
$ 39.14万 - 项目类别:
PHOSPH OF MCM2 BY CDC7 PROMOTES PRC ASSEMBLY DURING CELL-CYCLE RE-ENTRY
CDC7 对 MCM2 的磷酸化促进细胞周期重入期间的 PRC 组装
- 批准号:
8171473 - 财政年份:2010
- 资助金额:
$ 39.14万 - 项目类别:
The role of Cdc4/Fbw7 in Parkinson's Disease
Cdc4/Fbw7 在帕金森病中的作用
- 批准号:
8054203 - 财政年份:2009
- 资助金额:
$ 39.14万 - 项目类别:
The role of Cdc4/Fbw7 in Parkinson's Disease
Cdc4/Fbw7 在帕金森病中的作用
- 批准号:
7789612 - 财政年份:2009
- 资助金额:
$ 39.14万 - 项目类别:
相似国自然基金
系统性红斑狼疮粒-单核-树突细胞系中PLSCR1介导的I型干扰素诱导表达特征及调控机制研究
- 批准号:82300805
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
马口鱼精原干细胞系基因编辑与借腹怀胎研究
- 批准号:32373130
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
食蟹猴原始内胚层干细胞系的建立、谱系发生机制及谱系示踪
- 批准号:32270862
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
斜带石斑鱼精原干细胞系构建及细胞因子维持其自我更新的机制研究
- 批准号:32273132
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
干扰BMP信号通路逆转EGFR突变型肺腺癌继发耐药细胞系干性提高EGFR TKIs和放疗敏感性的研究
- 批准号:82272752
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
相似海外基金
The role of long noncoding RNA CRNDE in normal physiology and cancer
长链非编码RNA CRNDE在正常生理和癌症中的作用
- 批准号:
10715065 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别:
Functions of Tau protein in human neural cells
Tau蛋白在人类神经细胞中的功能
- 批准号:
10658624 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别:
The role of alpha-synuclein in nucleolar DNA double-strand break repair and cellular senescence
α-突触核蛋白在核仁 DNA 双链断裂修复和细胞衰老中的作用
- 批准号:
10677497 - 财政年份:2023
- 资助金额:
$ 39.14万 - 项目类别:
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer
ARF和ADAR1在三阴性乳腺癌中的拮抗作用
- 批准号:
10443312 - 财政年份:2022
- 资助金额:
$ 39.14万 - 项目类别:
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer
ARF和ADAR1在三阴性乳腺癌中的拮抗作用
- 批准号:
10571897 - 财政年份:2022
- 资助金额:
$ 39.14万 - 项目类别: